Group 1: Trade Policy Changes - The U.S. plans to impose a 50% tariff on all imported copper and up to 200% punitive tariffs on imported pharmaceuticals, marking a significant escalation in trade policy under the Trump administration [1][2] - The tariffs aim to encourage key industries to relocate manufacturing back to the U.S. and reduce reliance on foreign imports [1][2] Group 2: Copper Industry Impact - Copper is identified as a critical mineral essential for electronic products and clean energy supply chains, widely used in rechargeable batteries, wiring, and renewable energy vehicles [1] - In 2024, the U.S. is projected to mine approximately 1.1 million tons of copper, with one-third being exported, while imports are expected to be around 810,000 tons, primarily in refined form [2] Group 3: Pharmaceutical Industry Impact - The proposed 200% tariff on imported pharmaceuticals aims to compel pharmaceutical companies to manufacture domestically, thereby reducing dependence on overseas production [2] - This policy could significantly disrupt the global pharmaceutical supply chain, as most active pharmaceutical ingredients and generic drugs are produced abroad, potentially leading to increased prices for imported drugs and exacerbating domestic price pressures [2]
关键产业迎来“关税风暴” 特朗普拟对铜和药品征收重税
智通财经网·2025-07-08 22:27